Skip to main content
. 2015 Aug 31;7:463–476. doi: 10.2147/CEOR.S87462

Table S3.

Chi-square test “Is there evidence that acceptance rates above the accepted thresholds are higher for some therapeutic areas than for others?”

Number accepted Number rejected Total Expected accepted Expected rejected Chi squared accepted Chi squared rejected
Malignant disease and immunosuppression 37 94 131 37.00896861 93.99103139 2.17×10–6 8.56×10–7
Musculoskeletal and joint diseases 6 10 16 4.520179372 11.47982063 0.484465 0.020055
Infections 3 11 14 3.955156951 10.04484305 0.230667 0.090825
Nutrition and blood 3 11 14 3.955156951 10.04484305 0.230667 0.090825
Endocrine system 3 8 11 3.107623318 7.892376682 0.003727 0.001468
Skin 4 4 8 2.260089686 5.739910314 1.339455 0.52741
Central nervous system 2 5 7 1.977578475 5.022421525 0.000254 0.0001
Gastrointestinal system 1 5 6 1.695067265 4.304932735 0.285014 0.112224
Eye 2 4 6 1.695067265 4.304932735 0.054856 0.021599
Respiratory system 1 4 5 1.412556054 3.587443946 0.120493 0.047444
Obstetrics, gynecology, and urinary tract disorders 1 2 3 0.847533632 2.152466368 0.027428 0.0108
Cardiovascular system 0 1 1 0.282511211 0.717488789 0.282511 0.111239
Chi-square total 4.09353
P-value (χ2 test) 0.967101
P-value (df =11) 0.967101